Profenamine
This is an old revision of this page, as edited by Aoziwe (talk | contribs) at 12:44, 17 December 2019 (remove redirect). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
Trade names | Parsidol, Parsidan, Parkin |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Protein binding | 93% |
Elimination half-life | 1 to 2 hours |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.566 |
Chemical and physical data | |
Formula | C19H24N2S |
Molar mass | 312.48 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Profenamine (INN; also known as ethopropazine (BAN); trade names Parsidol, Parsidan, Parkin) is a phenothiazine derivative used as an antiparkinsonian agent[1] that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.
References
Dopaminergics |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||
Others | |||||||||||
|
Classes | |
---|---|
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |